Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

27-09-2017 | Image

Figure 3

Synthetic lethal (SL) interaction data from model organisms, such as data from TheCellMap or BioGRID, and tumour genomic sequence can be mined to discover new candidate SL interactions for validation in human cell lines, or direct SL interaction screening can be undertaken in human cell lines. Candidate SL interactions can be validated in genotypically defined cell line panels to determine whether SL interactions are conserved across cell lines or are limited to specific cell lines. RNAi, RNA interference

print
PRINT
Image Credits